N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 23.13 CNY -2.16% Market Closed
Market Cap: 9.3B CNY
Have any thoughts about
Nanjing Vazyme Biotech Co Ltd?
Write Note

Nanjing Vazyme Biotech Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing Vazyme Biotech Co Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Cash from Financing Activities
ÂĄ249.8m
CAGR 3-Years
-1%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Financing Activities
ÂĄ2.6B
CAGR 3-Years
-57%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Financing Activities
ÂĄ2.1B
CAGR 3-Years
-34%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Financing Activities
-ÂĄ893.3m
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Financing Activities
-ÂĄ2B
CAGR 3-Years
24%
CAGR 5-Years
-38%
CAGR 10-Years
-39%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Financing Activities
-ÂĄ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A
No Stocks Found

Nanjing Vazyme Biotech Co Ltd
Glance View

Market Cap
9.1B CNY
Industry
Biotechnology

Nanjing Vazyme Biotech Co., Ltd. is an intriguing player in the biotechnology sector, having carved a niche in the research, development, and production of an array of innovative biological reagents and solutions. Established in the vibrant city of Nanjing, this company stands at the crossroads of science and commerce, offering products that span across PCR reagents, protein engineering, and enzyme solutions. Their expertise is rooted in leveraging cutting-edge molecular biology, allowing the company to cater to a diverse clientele that includes academic research institutions, healthcare providers, and industries that require precise biochemical testing and analysis. Vazyme's growth story is intertwined with the fields of molecular diagnostics and life sciences, industries that have seen rapid advancements and heightened demand, especially in recent years. The company generates revenue predominantly through the sale of high-quality reagents that are essential for the accurate and reliable processing of biological data. By continually incorporating the latest scientific breakthroughs into their products, they ensure that their solutions remain at the forefront of the market. This strategy not only enhances their competitive edge but also solidifies customer loyalty and expands their market presence across the globe, establishing Vazyme as a key contributor to the biotechnology landscape.

Intrinsic Value
23.35 CNY
Undervaluation 1%
Intrinsic Value
Price
N

See Also

What is Nanjing Vazyme Biotech Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
249.8m CNY

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Cash from Financing Activities amounts to 249.8m CNY.

What is Nanjing Vazyme Biotech Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
50%

Over the last year, the Cash from Financing Activities growth was 216%. The average annual Cash from Financing Activities growth rates for Nanjing Vazyme Biotech Co Ltd have been -1% over the past three years , 50% over the past five years .

Back to Top